Method for extracting Yunnan camellia nitidissima phenolic compound, extracted Yunnan camellia nitidissima phenolic compound and application of Yunnan camellia nitidissima phenolic compound

High-purity phenolic compounds from Yunnan golden camellia leaves were extracted using a multi-step extraction method, which solved the problem of insufficient research in existing technologies and proved that they have antioxidant and antibacterial activities.

CN118930416APending Publication Date: 2024-11-12SOUTHWEST FORESTRY UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410978440.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-22
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

There is a lack of specific research on Yunnan golden camellia in the existing technology, and the related pharmacological effects lack scientific basis.

Method used

A multi-step extraction method was used to extract phenolic compounds from *Camellia yunnanensis* tea leaves, including reflux extraction, multiple extractions, resin separation, silica gel column chromatography, and high-performance liquid chromatography purification, to obtain high-purity compounds.

Benefits of technology

The high-purity extraction of phenolic compounds from Yunnan golden tea has been achieved, proving their antioxidant and antibacterial activities and providing scientific evidence.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118930416A_ABST
    Figure CN118930416A_ABST
Patent Text Reader

Abstract

The invention discloses an extraction method of Yunnan golden camellia phenolic compounds, which is characterized in that the high-purity Yunnan golden camellia phenolic compounds are purified and extracted from Yunnan golden camellia leaves by gradient elution, so that the Yunnan golden camellia phenolic compounds can be conveniently researched; the invention also discloses a Yunnan camellia nitidissima phenolic compound (omega-hydroxypigoguaiacone), and provides a chemical formula: C10H12O4 and a structural formula, so that related compounds can be artificially synthesized; the invention also provides application of the Yunnan golden camellia phenolic compound, and effective experiments prove that the Yunnan golden camellia phenolic compound has pharmacological effects of oxidation resistance and antibacterial activity.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of Yunnan golden camellia extraction, and in particular to a method for extracting phenolic compounds from Yunnan golden camellia, the extracted phenolic compounds from Yunnan golden camellia and uses thereof. Background Art

[0002] Yunnan Golden Camellia is a deciduous shrub of the Theaceae family, Camellia genus. It has golden petals and is a rare species in the camellia family. It is known as the "giant panda of the plant kingdom" and the "Queen of the Tea Family."

[0003] As a traditional folk medicine, the flowers and leaves of Yunnan Golden Camellia have been used as both medicine and food in my country for hundreds of years. According to the "Modern Compendium of Materia Medica" and "Guangxi Chinese Medicinal Materials Standards", Yunnan Golden Camellia can treat dysentery, bloody stools, tumors, hypertension and many other diseases.

[0004] Yunnan Golden Camellia not only contains a variety of amino acids and minerals needed by the human body, but is also rich in bioactive ingredients such as tea polyphenols, saponins, flavonoids, and tea polysaccharides.

[0005] However, there is a lack of specific research on Yunnan golden camellia in the prior art, and the relevant pharmacological effects also lack scientific basis. Summary of the invention

[0006] In order to solve the above-mentioned multiple defects caused by the prior art, the present invention provides a method for extracting phenolic compounds from Yunnan golden camellia, and the extracted phenolic compounds from Yunnan golden camellia fill the gap in the prior art.

[0007] To achieve the above object, the present invention provides the following technical solutions:

[0008] A method for extracting phenolic compounds from Yunnan golden camellia, characterized in that it comprises the following steps:

[0009] Step 001, grinding a dry sample of Yunnan Camellia chrysantha tea leaves, and condensing and refluxing the dried sample with industrial methanol to obtain a Yunnan Camellia chrysantha methanol extract;

[0010] Step 002, recovering industrial methanol from the Yunnan Camellia chrysantha methanol extract by an evaporator to obtain Yunnan Camellia chrysantha methanol extract;

[0011] Step 003, adding equal volumes of distilled water and industrial ethyl acetate to the Yunnan Camellia chrysantha methanol extract, performing multiple extractions, and then obtaining the Yunnan Camellia chrysantha ethyl acetate extract through an evaporator;

[0012] Step 004, mixing the Yunnan Camellia chrysantha ethyl acetate extract with a macroporous resin, and loading the mixture into a chromatographic column for separation, and performing thin layer chromatography on the separated products, and mixing the separated products with the same chromatographic results to obtain the Yunnan Camellia chrysantha extract;

[0013] Step 005, mixing Yunnan Camellia chrysantha extract with silica gel, and loading the mixture into a chromatographic column for separation, and performing thin layer chromatography on the separated products, and combining separated products with the same chromatographic results to obtain multiple components;

[0014] Step 006, selecting one component from the components obtained in step 005 and performing MCI companion column chromatography to obtain multiple components;

[0015] Step 007, selecting a component from the components obtained in step 006, and performing multiple purification steps to remove impurities to obtain a monomer compound.

[0016] Furthermore, in step 004, V 水 / 甲醇 =1:0-0:1 for gradient elution.

[0017] Furthermore, in step 005, V 氯仿 / 甲醇 =50:1-1:1 for gradient elution.

[0018] Further, in step 006, MCI companion column chromatography is performed to obtain V 甲醇 / 水 =40%-100% was subjected to TLC segmentation.

[0019] Further, in step 007, at least two purification processes are performed, including:

[0020] Step 071, select a component from the components obtained in step 006, and use Sephadex LH-20 (V 甲醇 / 水 =95:5) further purified and impurity removed to obtain multiple components;

[0021] Step 072, selecting a component from the components obtained in step 071, and purifying it using preparative high performance liquid chromatography (PHPLC) to obtain a monomer compound.

[0022] To achieve the above object, the present invention provides the following technical solutions:

[0023] A compound extracted by using a method for extracting phenolic compounds from Yunnan golden camellia,

[0024] The molecular formula of the compound is: 10 H 12 O 4 ;

[0025] The structural formula of the compound is:

[0026]

[0027] To achieve the above object, the present invention provides the following technical solutions:

[0028] A use of a Yunnan golden camellia phenolic compound, wherein the compound has an antioxidant pharmacological effect.

[0029] Furthermore, the compound also has the pharmacological effect of antibacterial activity.

[0030] The beneficial effects of adopting the above technical solution are:

[0031] The invention provides a method for extracting phenolic compounds from Yunnan golden camellia, and gradient elution is used to purify and extract high-purity phenolic compounds from Yunnan golden camellia tea leaves, so as to facilitate research on the phenolic compounds from Yunnan golden camellia.

[0032] The present invention also provides a Yunnan golden camellia phenolic compound, and provides a chemical formula and a structural formula, so that related compounds can be artificially synthesized.

[0033] The invention also provides the use of the Yunnan golden camellia phenolic compound, and through effective experiments, it is proved that the Yunnan golden camellia phenolic compound has the pharmacological effects of anti-oxidation and antibacterial activity. BRIEF DESCRIPTION OF THE DRAWINGS

[0034] Figure 1 The present invention is a flow chart of the method for extracting phenolic compounds from Yunnan golden camellia. DETAILED DESCRIPTION

[0035] The preferred embodiments of the present invention will be described in detail below with reference to the accompanying drawings.

[0036] The voucher specimen of Camellia chrysantha (52860) was identified by taxonomist Min Tianlu and is kept in the herbarium of Kunming Institute of Botany, Chinese Academy of Sciences. The tea leaves of Camellia chrysantha used in this experiment were obtained from Daweishan Nature Reserve, Hekou County, Yunnan Province, China in December 2019 and identified as Camellia chrysantha by Professor Xiang Jianying, a taxonomist at Southwest Forestry University.

[0037] The experimental instruments used are as follows:

[0038] BrukerAV 500MHz nuclear magnetic resonance instrument (Bruker, Germany), XEVO G2-XS Q-Tof high-resolution mass spectrometer (Waters, USA), NP7000 semi-preparative liquid phase (Jiangsu Hanbang Technology Co., Ltd., China), AX224ZH\E electronic balance (Ohaus Instrument (Changzhou) Co., Ltd., China), 101-2ES electric heating blast drying oven (Beijing Yongguangming Medical Instrument Co., Ltd., China), N-1300 rotary evaporator, CA-111 cold trap (Shanghai Ailang Instrument Co., Ltd., China), SHZ-DⅢ circulating water vacuum pump (Gongyi Yuhua Instrument Co., Ltd., China), ZF-7 three-purpose UV analyzer (Shanghai Jiapeng Technology Co., Ltd., China), column chromatography process reagents are all industrial grade.

[0039] like Figure 1 As shown, the present invention provides a method for extracting phenolic compounds from Yunnan golden camellia, comprising the following steps:

[0040] Step 001, take 10.7 kg of dry Yunnan Camellia chrysantha tea leaf sample, crush it into about 40 mesh, mix it with 95% industrial methanol, pour it into a round-bottom flask and heat it until it reaches 50° C. and keep the temperature constant.

[0041] The methanol will evaporate as a vapor, rise through the condenser, and then condense into a liquid in the cooled part of the condenser and flow back into the flask.

[0042] The extraction was performed by condensation reflux for 3 times, each time for 3 h, 2 h and 1 h respectively, and the extracted solutions were combined to obtain the methanol extract of Camellia chrysantha.

[0043] Step 002, pour the methanol extract of Yunnan Camellia chrysantha into the flask of the evaporator, start the vacuum pump, and gradually reduce the pressure in the evaporator, which helps to lower the boiling point of methanol and make it evaporate at a lower temperature, and heat the solution in the flask through the heater.

[0044] As the pressure decreases and the temperature is increased, methanol will begin to evaporate (evaporation temperature is 50°C); the evaporated methanol will condense in the condenser and then flow into the receiving bottle; when most of the methanol has evaporated, turn off the heater and vacuum pump and let the system cool naturally.

[0045] The mixture was extracted from the receiving bottle to obtain 868.3 g of Yunnan Camellia chrysantha methanol extract.

[0046] Step 003, add 5L of distilled water to the methanol extract of Camellia chrysantha to mix it thoroughly, then put it into a separatory funnel and add an equal volume of industrial ethyl acetate.

[0047] Close the separatory funnel and shake it upside down to allow ethyl acetate to fully contact the mixture, which helps transfer the target compound from the aqueous phase to the organic phase. After shaking, place the separatory funnel in a stable place and let the mixture stand until the organic phase and the aqueous phase are completely separated.

[0048] When the two phases are clearly separated, open the piston of the separatory funnel, release the aqueous phase, and collect the ethyl acetate solution in the organic phase.

[0049] Repeat the above steps and fully extract 3 times.

[0050] Then, the mixture was heated to 40°C and subjected to low-pressure rotary evaporation to obtain 177.8 g of Yunnan Camellia chrysantha ethyl acetate extract.

[0051] Step 004, mixing the Yunnan Camellia chrysantha ethyl acetate extract with a macroporous resin and loading it onto a column to remove impurities in the sample or enrich the target compound.

[0052] The macroporous resin is soaked and washed in an appropriate solvent to remove impurities that may affect the separation.

[0053] 175.0 g of Yunnan Camellia chrysantha ethyl acetate extract was mixed with a macroporous resin, and the mixture was loaded into a chromatographic column for separation.

[0054] V 水 / 甲醇 =1:0-0:1 for gradient elution. As the eluent flows, the target compound will gradually flow out of the column. Use a receiving bottle to collect the separated products at different times or volumes.

[0055] The collected fraction needs to be further dried and purified, such as by concentration or crystallization.

[0056] Afterwards, the isolates were subjected to thin layer chromatography and the isolates with the same chromatogram were mixed to obtain Yunnan Camellia chrysantha extract.

[0057] The mobile phases for gradient elution are: water, V 水 / 甲醇 =3:7, V 水 / 甲醇 =4:6, V 水 / 甲醇 =1:9.

[0058] Step 005, performing silica gel column chromatography on the Yunnan Camellia chrysantha extract to separate compounds of different polarities through the adsorption of silica gel.

[0059] Mix 45.0g of Yunnan Camellia chrysantha extract with 70.0g of silica gel, 200-300 mesh; make the Yunnan Camellia chrysantha extract evenly adsorbed on the silica gel; when mixing the sample, be careful to avoid excessive stirring to prevent the silica gel from agglomerating.

[0060] Suspend silica gel (320.0 g silica gel, 200-300 mesh) using an appropriate solvent (usually a less polar solvent such as n-hexane or chloroform), and then pack the silica gel into the chromatography column to avoid generating bubbles.

[0061] Before loading the column, equilibrate the column with the same solvent used to pack the column until the solvent flows out from the bottom of the column to ensure that the column reaches a stable state.

[0062] The silica gel and Yunnan golden camellia extract mixture was loaded into the chromatographic column and 氯仿:甲醇 =50:1-1:1 for gradient elution. As the eluent flows, the target compound will gradually flow out of the column; use a receiving bottle to collect the separated products at different times or volumes.

[0063] The isolate was subjected to thin layer chromatography and the same parts were combined to obtain 9 components (Fr.AI) by TLC.

[0064] Step 006, select Fr. A group to perform MCI companion column chromatography for separation and purification.

[0065] The Fr.A group to the Fr.I group were screened for their in vitro antioxidant and antibacterial activities, and the Fr.A group was selected based on the results. The relevant screening data of the Fr.A group are attached, as shown in Tables 1 and 2.

[0066] Table 1. Antioxidant activity of components from Yunnan Camellia chrysantha

[0067]

[0068] Table 2. Antimicrobial activity of components from Yunnan Camellia chrysantha

[0069]

[0070] Select appropriate MCI gel, fill the chromatographic column, and mix the components of Fr.A group with the MCI gel so that the components are uniformly adsorbed on the gel.

[0071] V 甲醇 / 水 =40%-100% gradient elution was performed, and as the eluent flowed, the target compound would gradually flow out of the column; a receiving bottle was used to collect the separations at different times or volumes to obtain 9 components (Fr.AA-AI).

[0072] Among them, the mobile phases for gradient elution are: V 甲醇 / 水 =2:3, V 甲醇 / 水 =1:1, V 甲醇 / 水 =3:2, V 甲醇 / 水 =7:3, V 甲醇 / 水 =4:1, V 甲醇 / 水 =9:1, V 甲醇 / 水 =10:0.

[0073] Step 007, select the Fr.AA group and perform molecular sieve chromatography using Sephadex LH-20.

[0074] Among them, the amount of Fr.AA is relatively large, and the TLC display points are the same as the main part of the TLC display of Fr.A. It is preliminarily judged that this part of Fr.AA may be the main active segment of Fr.A, so the Fr.AA group is selected for the next step of separation and purification.

[0075] Sephadex LH-20 is a dextran-derived gel commonly used in molecular sieving chromatography, especially for the separation of biomolecules such as proteins, peptides, nucleic acids, lipids and certain small molecules. It has good chemical stability and biocompatibility.

[0076] Soak Sephadex LH-20 gel in distilled water until the gel volume expands to 3-4 times of its original volume; wash the expanded gel thoroughly with distilled water to remove impurities that may affect chromatographic separation, and then fill the column.

[0077] The components of the Fr.AA group were loaded so as to be adsorbed on the gel.

[0078] V 甲醇 / 水 =95:5 for elution, purification and impurity removal to obtain 4 components (Fr.AAa-AAd).

[0079] Step 008, selecting the Fr.AAa group, and finally purifying it using preparative high performance liquid chromatography (PHPLC) to obtain a monomer compound.

[0080] The amount of Fr.AAa is large, and the TLC display points are the same as the main parts of Fr.AA. It is preliminarily judged that this part of Fr.AAa may be the main active segment of Fr.AA, so the Fr.AAa group is selected for the next step of separation and purification.

[0081] The invention also discloses a Yunnan golden camellia phenolic compound, which is extracted from Yunnan golden camellia tea leaves by the extraction method.

[0082] The molecular formula of this compound is: C 10 H 12 O 4 ; The structural formula of the compound is:

[0083]

[0084] The compound is a colorless oil, HRESI-MS m / z 195.0620[MH] - .

[0085] 1 H NMR (500MHz, Methanol-d 4 )δ H 7.58(1H,dd,J=8.3,2.0Hz,H-6'),7.43(1H,d,J=2.0Hz,H-2'),6.92(1H,d,J=8.3 Hz,H-5'),4.32(3H,s,OMe)3.93(2H,t,J=6.1Hz,H-3),3.16(2H,t,J=6.2Hz,H-2).

[0086] 13 C NMR (126MHz, Methanol-d 4 )δ C 200.2(C-1),154.2(C-3'),149.7(C-4'),131.0(C-1'),125.3(C-6'),116.4(C-5'),112.4(C-2'),59.5(C-3),56.9(OMe),42.2(C-2).

[0087] The invention discloses a use of a Yunnan golden camellia phenolic compound, and the compound has an antioxidant pharmacological effect.

[0088] The experiment used a 96-well plate with a total volume of 210 μL per well.

[0089] Equal volumes of ABTS solution (7 mM) and potassium persulfate solution (5 mM) were mixed evenly and reacted in the dark at room temperature for 12 h to obtain an ABTS radical cation stock solution; then, the mixture was diluted with anhydrous methanol so that its absorbance value at 734 nm was about 0.7±0.02.

[0090] Add 180 μL of ABTS working solution to each well, and then add 30 μL of samples of different concentrations (0.5, 0.1, 0.05, 0.01 μg / mL), dissolve and dilute with DMSO.

[0091] After mixing well, the samples were incubated at room temperature in the dark for 6 min; then, the absorbance value of each well was measured at 734 nm using a microplate reader, and the results were obtained from at least three independent experiments.

[0092] Ascorbic acid was used as a positive control.

[0093] The ABTS radical cation scavenging rate (%) of each test sample was calculated as follows:

[0094] ABTS clearance rate (%) = [blank - (sample - control)] / blank × 100%;

[0095] The ABTS test results are shown in Table 3:

[0096] Table 3. Antioxidant activity of tea phenols

[0097]

[0098] The invention discloses a use of a Yunnan golden camellia phenolic compound, and the compound also has a pharmacological effect of antibacterial activity.

[0099] Preparation of antimicrobial drug stock solution: Dissolve the drug in dimethyl sulfoxide to a mass concentration of 0.5 mg / mL.

[0100] Preparation of the test bacterial solution: The frozen bacterial solution taken out from the -80℃ low-temperature storage box was thawed at room temperature, and the nutrient broth (NB) medium was sterilized and cultured overnight in a 37℃ shaker; 2mL of the overnight cultured bacterial solution was inoculated into the NB medium and cultured at 37℃ until A 600 =0.5, and then diluted 100 times with NB medium.

[0101] Microbroth dilution method: Take a sterile 96-well plate, add 75 μL of NB culture medium diluent to wells A2-A11, add 75 μL of drug solution to wells A1-A2, take 75 μL of the mixture from well A2 to well A3, take 75 μL of the mixture from well A3 to well A4, take 75 μL of the mixture to well A10, discard, then add 75 μL of 5% DMSO to well 12, add 75 μL of 5% DMSO to well A12, add 75 μL of bacterial solution to well A12, and mix well.

[0102] After inoculation, the 96-well plate was incubated at 37 °C for 14 h, the growth was observed, and the A 600 , calculate the MIC.

[0103] The antibacterial test results are shown in Table 4:

[0104] Table 4. Antibacterial activity of tea phenol compounds

[0105]

[0106] Among them, due to the quantity of the compound, the other two foodborne bacteria (Staphylococcus aureus and Pseudomonas aeruginosa) were not screened for antimicrobial activity.

[0107] The above is only a preferred embodiment of the present invention. It should be pointed out that a person skilled in the art can make several modifications and improvements without departing from the inventive concept of the present invention, which all belong to the protection scope of the present invention.

Claims

1. A method for extracting phenolic compounds from Yunnan golden camellia. It is characterized in that The following steps are involved: Step 001, crushing a dry sample of Yunnan Camellia chrysantha tea leaves, and condensing and refluxing the dried sample with industrial methanol to obtain a Yunnan Camellia chrysantha methanol extract; Step 002, recovering industrial methanol from the Yunnan Camellia chrysantha methanol extract by an evaporator to obtain Yunnan Camellia chrysantha methanol extract; Step 003, adding equal volumes of distilled water and industrial ethyl acetate to the Yunnan Camellia chrysantha methanol extract, performing multiple extractions, and then obtaining the Yunnan Camellia chrysantha ethyl acetate extract through an evaporator; Step 004, mixing the Yunnan Camellia chrysantha ethyl acetate extract and the macroporous resin D101 companion sample, loading the mixture into a chromatographic column for separation, performing thin layer chromatography on the separated products, and mixing the separated products with the same chromatographic results to obtain the Yunnan Camellia chrysantha extract; Step 005, mixing Yunnan Camellia chrysantha extract with silica gel, and loading the mixture into a chromatographic column for separation, and performing thin layer chromatography on the separated products, and combining separated products with the same chromatographic results to obtain multiple components; Step 006, selecting one component from the components obtained in step 005 and performing MCI companion column chromatography to obtain multiple components; Step 007, selecting a component from the components obtained in step 006, and performing multiple purification steps to remove impurities to obtain a monomer compound.

2. According to claim 1, It is characterized in that In step 004, V 水 / 甲醇 =1:0-0:1 for gradient elution.

3. According to claim 1, It is characterized in that In step 005, V 氯仿 / 甲醇 =50:1-1:1 for gradient elution.

4. According to claim 1, It is characterized in that In step 006, MCI companion column chromatography is used to obtain V 甲醇 / 水 =40%-100%, and TLC segmentation was performed.

5. According to claim 1, It is characterized in that In step 007, at least two purification steps are performed, including: Step 071, select a component from the components obtained in step 006, and further purify and remove impurities using Sephadex LH-20 to obtain multiple components, wherein V 甲醇 / 水 =95:5 for elution; Step 072, selecting a component from the components obtained in step 071, and purifying it using preparative high performance liquid chromatography (PHPLC) to obtain a monomer compound.

6. A phenolic compound of Yunnan golden camellia extracted by the extraction method according to any one of claims 1 to 5, It is characterized in that The molecular formula of the compound is: C10H12O4; The structural formula of the compound is:

7. A use of the phenolic compounds of Yunnan golden camellia according to claim 6, It is characterized in that The compound has an antioxidant pharmacological effect.

8. The use of the Yunnan golden camellia phenolic compounds according to claim 7, It is characterized in that The compounds also have antibacterial activity.